- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01557387
Real-time Diagnosis of Pseudopolyps During Colonoscopy
Real-time Diagnosis of Pseudopolyps During Colonoscopy Using Noninvasive Advanced Endoscopic Techniques - a Prospective Study
Significance: Biopsy of potentially benign pseudopolyps and the surrounding mucosa adds expense and prolongs the time of endoscopic procedures. Use of endoscopic technologies could decrease the need and expense of endoscopic biopsy for these lesions.
Hypothesis: Pseudopolyps will have a distinctive pattern with the specialized imaging techniques of high definition imaging, narrow band imaging, and endoscopic dye-spraying techniques using indigo carmine which will predict diagnosis without biopsy.
100 patients with inflammatory bowel disease will be enrolled in the study. Following a standard bowel preparation, each patient will be evaluated using standard endoscopic equipment. All patients will receive a standard bowel preparation (sodium phosphate, PEG-3350, or magnesium citrate based preparations). All colonoscopic evaluations will be performed for indications unrelated to the present study, including evaluation of response to medical treatment, routine surveillance exams for dysplasia, diarrhea, or rectal bleeding. Polypoid lesions will be examined using four consecutive methods: (a) high definition white light, (b) narrow band imaging, (c) chromoendoscopy (high definition white light with indigo carmine dye-spraying), and (d) histologic examination following biopsy. The flat mucosa surrounding the polypoid lesions will also be examined using theses four techniques in an effort to identify dysplastic tissue associated with these polypoid growths.
High definition white light is the standard imaging modality used for colonoscopy. Narrow band imaging (blue wavelength of light) is also used routinely and is available on all current generation colonoscopes with the press of a button. Our division routinely uses chromoendoscopy as part of surveillance for dysplasia in patients with inflammatory bowel disease. Dye spraying catheters or flushing will be utilized for dye application to mucosa. The dye used will be indigo carmine.
Directed biopsy specimens will then be performed using a multibite forceps for targeted biopsies. Routine biopsies will be performed as clinically indicated. Pathology slides will be reviewed by the gastrointestinal pathologists at the University of Miami. The gastroenterologist's interpretation based on each of the three successive endoscopic methods will then be compared to the histologic evaluation with each individual lesion serving as its own control.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The colonoscopy with biopsies will be done as standard of care; additional biopsies will be taken for research purposes as detailed above. All of the imaging techniques are part of the accepted standard of care as follows: high definition white light, narrow band imaging, chromoendoscopy, and histologic examination following biopsy. Comparison of the predictive values of the imaging modalities in predicting histology from biopsy underlies the primary question of this research protocol. Cost analysis of modalities versus histology will also be performed. Time for use of the individual modalities will be recorded.
Subjects will be identified by one of the investigators during their outpatient clinic visits or while inpatient at University of Miami Hospital. Subjects who meet the inclusion/exclusion criteria and are scheduled to undergo a colonoscopy for standard of care purposes will be asked to participate in the study. Patients over 18 years of age with a confirmed diagnosis of inflammatory bowel disease with plans for routine colonoscopic evaluation and able to provide informed consent will be included.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami Hospital
-
Miami, Florida, United States, 33136
- University of Miami Hospital and Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients equal to or over 18 years of age with a confirmed diagnosis of inflammatory bowel disease with plans for routine colonoscopic evaluation and able to provide informed consent will be included.
Exclusion Criteria:
- Patients under 18 years of age.
- Patient unwilling or unable to undergo colonoscopy with biopsies or preparation for colonoscopy.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with pseudopolyps.
No treatment involved in this study.
|
All patients will undergo non-invasive endoscopic techniques considered standard of care in surveillance for dysplasia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Accuracy of non-invasive endoscopic techniques for diagnosis of pseudopolyps as compared to histology as the gold standard for diagnosis
Time Frame: 2 years or until 100 patients enrolled, whichever comes first
|
2 years or until 100 patients enrolled, whichever comes first
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cost of non-invasive endoscopic techniques for diagnosis of pseudopolyps as compared to histology as the gold standard for diagnosis
Time Frame: 2 years or until 100 patients enrolled, whichever comes first
|
2 years or until 100 patients enrolled, whichever comes first
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel A Sussman, MD, MSPH, University of Miami Division of Gastroenterology
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20091017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Disease
-
Cook Children's Health Care SystemNot yet recruitingIBD | IBD - Inflammatory Bowel Disease | IBD (Inflammatory Bowel Disease)United States
-
Ningbo Medical Center Lihuili HospitalRecruitingInflammatory Bowel Disease (IBD)China
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingIBD - Inflammatory Bowel DiseaseItaly
-
Chang Kyun LeeChonnam National University Hospital; Kyungpook National University Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine and other collaboratorsRecruitingInflammatory Bowel Disease (IBD)Korea, Republic of
-
Centre Hospitalier Universitaire, AmiensFunding from DGOS (PHRC IR 2013 and PRME)CompletedPediatric Inflammatory Bowel DiseaseFrance
-
Assiut UniversityNot yet recruitingInflammatory Bowel Disease (IBD)
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University Hospital, GrenobleInstitute for Advanced Biosciences (IAB), GrenobleNot yet recruitingInflammatory Bowel Disease (IBD)France
-
The Second Hospital of Nanjing Medical UniversityNot yet recruiting
Clinical Trials on Endoscopic techniques
-
Centre de Recherche de l'Institut Universitaire...TerminatedTracheal StenosisFrance, Canada
-
University of British ColumbiaHadassah Medical Organization; Vancouver Coastal Health Research Institute; Providence... and other collaboratorsRecruitingColon Adenoma | Colon Polyp | Colon LesionCanada, United States, Israel
-
Jagiellonian UniversityNot yet recruitingRectal Cancer | Rectal Adenocarcinoma | Rectal Adenoma | Recurrent Rectal Adenocarcinoma | Rectal Neuroendocrine NeoplasmPoland
-
Jilin UniversityRecruitingRectal Neuroendocrine Tumors | ESD | EPMRChina
-
EPC Education s.r.o.CompletedChronic Pain | Sacroiliac Joint PainSlovakia
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Not yet recruitingRectal Neuroendocrine Tumors
-
Robert Bosch Gesellschaft für Medizinische Forschung...Ovesco Endoscopy AG; Tuebingen Scientific Medical GmbHRecruitingAdenoma Colon | Adenoma Colon PolypGermany
-
University Hospital, ToulouseCompleted
-
Mayo ClinicEnrolling by invitationHealthy | Bariatric Surgery Candidate | ObeseUnited States
-
Azienda USL Reggio Emilia - IRCCSRecruitingEsophageal Neoplasms | Colonic Neoplasms | Gastric Neoplasm | Duodenal Neoplasms | Endoscopic Submucosal Dissection | Endoscopic Mucosal ResectionItaly